Top compounds associated with response to TAS2R8


Feature Type Standardized
Nominal ANOVA
mRNA decitabine CTRPv2 pan-cancer AAC 0.075 0.005
mRNA AGK-2 CTRPv2 pan-cancer AAC 0.1 0.005
mRNA Erlotinib CCLE pan-cancer AAC -0.13 0.006
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.006
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.084 0.006
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.006
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.093 0.006
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC 0.096 0.007
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.083 0.007
mRNA Bax channel blocker CTRPv2 pan-cancer AAC 0.099 0.008
Download CSV